Overview

Lung Pharmacokinetics (PK) in Epithelial Lining Fluid (ELF)

Status:
Completed
Trial end date:
2019-04-30
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to measure and compare the concentration of AAI101 and cefepime in bronchial epithelial lining fluid (ELF) and plasma following administration of cefepime/AAI101 combination in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Allecra
Treatments:
Cefepime